Granules India gets USFDA tentative nod for generic ADHD treatment tablets

New Delhi: Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health regulator for its generic amphetamine extended-release tablets indicated for…

Trump’s tariffs on India: What forced the US govt to leave Indian pharma out of the 50% tax bracket?

The Indian pharmaceutical industry has been exempted from immediate tariff increases in the US due to the significance of generic medications for providing affordable healthcare in the country. This decision…